Influenza A virus can create acute respiratory infection in humans and animals throughout
the world, and it is still one of the major causes of morbidity and mortality in humans …

The antiviral response against influenza A virus (IAV) infection includes the induction of the
interferon (IFN) signaling pathway, including activation of the STATs protein family …

Influenza virus A (IVA) is one of the predominant causative agents of the seasonal flu and
has become an important cause of morbidity worldwide. Great efforts have been paid to …

Influenza A viruses (IAVs) continuously challenge the poultry industry and human health.
Elucidation of the host factors that modulate the IAV lifecycle is vital for developing antiviral …

Acute respiratory infections caused by influenza A virus (IAV) spread widely and lead to
substantial morbidity and mortality. Host cell induction of type I interferon (IFN-I) plays a …

For most frequent respiratory viruses, there is an urgent need for a universal influenza
vaccine to provide cross-protection against intra-and heterosubtypes. We previously …

Immune surveillance by natural killer (NK) cells and their recruitment to sites of inflammation
renders them susceptible to viral infection, potentially modulating their effector function …

Abstract H5N1 influenza A virus (IAV) causes severe respiratory diseases and high mortality
rates in animals and humans. MicroRNAs are being increasingly studied to evaluate their …

Influenza viruses are respiratory pathogens that are major threats to human health. Due to
the emergence of drug-resistant strains, the use of traditional anti-influenza drugs has been …

Virus-Like Particles (VLPs) are nanostructures that share conformation and self-assembly
properties with viruses, but lack a viral genome and therefore the infectious capacity. In this …